1. Home
  2. IHD vs RVPH Comparison

IHD vs RVPH Comparison

Compare IHD & RVPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IHD
  • RVPH
  • Stock Information
  • Founded
  • IHD 2011
  • RVPH 2006
  • Country
  • IHD United States
  • RVPH United States
  • Employees
  • IHD N/A
  • RVPH N/A
  • Industry
  • IHD Investment Managers
  • RVPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • IHD Finance
  • RVPH Health Care
  • Exchange
  • IHD Nasdaq
  • RVPH Nasdaq
  • Market Cap
  • IHD 89.7M
  • RVPH 88.0M
  • IPO Year
  • IHD N/A
  • RVPH N/A
  • Fundamental
  • Price
  • IHD $5.26
  • RVPH $1.80
  • Analyst Decision
  • IHD
  • RVPH Strong Buy
  • Analyst Count
  • IHD 0
  • RVPH 5
  • Target Price
  • IHD N/A
  • RVPH $11.40
  • AVG Volume (30 Days)
  • IHD 27.7K
  • RVPH 1.6M
  • Earning Date
  • IHD 01-01-0001
  • RVPH 11-14-2024
  • Dividend Yield
  • IHD 10.32%
  • RVPH N/A
  • EPS Growth
  • IHD N/A
  • RVPH N/A
  • EPS
  • IHD N/A
  • RVPH N/A
  • Revenue
  • IHD N/A
  • RVPH N/A
  • Revenue This Year
  • IHD N/A
  • RVPH N/A
  • Revenue Next Year
  • IHD N/A
  • RVPH N/A
  • P/E Ratio
  • IHD N/A
  • RVPH N/A
  • Revenue Growth
  • IHD N/A
  • RVPH N/A
  • 52 Week Low
  • IHD $4.49
  • RVPH $0.60
  • 52 Week High
  • IHD $5.47
  • RVPH $4.50
  • Technical
  • Relative Strength Index (RSI)
  • IHD 60.01
  • RVPH 45.36
  • Support Level
  • IHD $5.11
  • RVPH $1.97
  • Resistance Level
  • IHD $5.27
  • RVPH $2.14
  • Average True Range (ATR)
  • IHD 0.05
  • RVPH 0.16
  • MACD
  • IHD 0.01
  • RVPH -0.02
  • Stochastic Oscillator
  • IHD 90.91
  • RVPH 29.29

About IHD Voya Emerging Markets High Income Dividend Equity Fund

Voya Emerging Markets High Dividend Equity Fund is a diversified closed-end management investment company. Its primary investment objective is to provide total return through a combination of current income, capital gains, and capital appreciation. The company seeks to achieve its investment objectives by investing principally in a portfolio of equity securities, and issuers in emerging market countries. The Fund will also normally seek to secure gains and enhance the stability of returns over a market cycle by writing (selling) call options on selected exchange-traded funds (ETFs) and/or international, regional, or country indices of equity securities, and/or on equity securities.

About RVPH Reviva Pharmaceuticals Holdings Inc.

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.

Share on Social Networks: